Planning a Clinical Trial: 3 Factors CROs Consider That Sponsors Rarely Do

Clinical Research Organizations (CRO) are the experts in clinical trial feasibility and the go-to-partner for helping biotech and pharma companies research, evaluate and launch their novel compound or medical device. And in fact, the CRO market has been growing in the last few years and is expected to reach $44bln …

Planning a Clinical Trial: 3 Factors CROs Consider That Sponsors Rarely Do Read More »

The One Thing Your Decentralized Clinical Trial Strategy Is Missing

Recently, Maya Zlatanova’s article Decentralized Clinical Trials Across Europe: Regulatory and Other Practical Considerations was published in DIA’s Global Forum. The piece highlights the most important considerations for planning and conducting decentralized clinical trials in Europe – from the different ‘readings’ of EMA’s guidelines depending on the country to the mindset of the patients depending …

The One Thing Your Decentralized Clinical Trial Strategy Is Missing Read More »

CROs: How to Go From an RFP to a Bid Defense to Winning the Project

Planning a clinical trial means juggling and balancing multiple factors and priorities. In fact, a successful trial is so much more than managing data, sites, patients and hoping for a fruitful outcome. Pharma and biotech companies need to ensure that their future trial is in alignment with internal and external …

CROs: How to Go From an RFP to a Bid Defense to Winning the Project Read More »

2 Reasons Big Pharma Companies Like Novartis And Bayer Plan Their Clinical Trials Internally

Big Pharma’s R&D is a daily focus and their huge pipeline requires careful consideration. This includes, of course, the clinical research section. In fact, even Big Pharma relies on Clinical Research Organisations (CRO) to run their clinical trials – at least in part. In the last few months, I spent …

2 Reasons Big Pharma Companies Like Novartis And Bayer Plan Their Clinical Trials Internally Read More »

Scroll to Top